Aurobindo Pharma Limited Aurobindo Pharma Limited

Aurobindo Pharma Limited

AUROPHARMA

株式のランク #2067
Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures,... Aurobindo Pharma Limited, a biopharmaceutical company, develops, manufactures, commercializes, and sells generic pharmaceuticals, active pharmaceutical ingredients (APIs), and injectables. The company offers formulation in form of oral solids, liquids, injectables, vaccines, and metered dose inhalers; and APIs, biosimilars, and peptides targeting therapeutic areas, such as central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and API space for sterile and non-sterile penicillin’s, cephalosporins, penems, and non-beta lactams. The company has operations in India, the United States, Europe, Puerto Rico, and internationally. The company was incorporated in 1986 and is headquartered in Hyderabad, India.
株価
$17.34
時価総額
$9.98B
変化(1日)
-3.08%
変化(1年)
38.71%
国
IN
取引 Aurobindo Pharma Limited (AUROPHARMA)

カテゴリー

Healthcare
Aurobindo Pharma Limited(AUROPHARMA)の配当利回りの履歴
Aurobindo Pharma Limited(銘柄コード: AUROPHARMA)の配当利回り(TTM)は2024-03-31時点で0.40%です。
過去5年間の平均配当利回り: 0.59%
Aurobindo Pharma Limited(AUROPHARMA)の2004から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
年 配当利回り 変化
2026 (TTM) 0.00% -100.00%
2025 0.00% -100.00%
2024 0.40% -72.41%
2023 1.45% 116.42%
2022 0.67% 48.89%
2021 0.45% -38.36%
2020 0.73% 135.48%
2019 0.31% -50.79%
2018 0.63% 117.24%
2017 0.29% -6.45%
2016 0.31% -27.91%
2015 0.43% 7.50%
2014 0.40% -73.68%
2013 1.52% 55.10%
2012 0.98% 16.67%
2011 0.84% 50.00%
2010 0.56% -85.60%
2009 3.89% 285.15%
2008 1.01% 288.46%
2007 0.26% 225.00%
2006 0.08% -91.01%
2005 0.89% 78.00%
2004 0.50% 0.00%
類似企業または競合他社の配当利回り(TTM)